The latest from Robert Whitaker on the long term studies that we – those who have been conditioned to believe in and use these drugs – have not been told of.
An excerpt:
Of all the research that has been done in the past 20 years on psychotic disorders, Martin Harrow’s ongoing study of long-term outcomes in such patients is, in my opinion, the most important work. He and his colleagues have now published their 20-year results. Given the 15-year outcomes data he published in 2007, his latest findings should not be surprising. The schizophrenia and schizoaffective patients who took antipsychotics regularly during the 20 years, compared to those who quit taking the medications usually within the first two years, experienced more psychosis, more anxiety, and markedly fewer periods of “sustained recovery.”� They were also more cognitively impaired.The same dramatic difference in outcomes was seen in patients diagnosed with a mood disorder with psychotic features: �those who stayed on antipsychotics fared markedly worse over the long-term.The psychiatric establishment mostly ignored Harrow’s 2007 report, or tried to explain away his findings. But with the publication of the 20-year results, I think the time has come for psychiatry—and our society—to take a close look at his research, and to try to honestly assess what is going on. A full-bodied inquiry is essential for another reason too: We are now prescribing antipsychotics to an ever larger number of children, and to many non-psychotic adults as well, and if antipsychotics are worsening the long-term outcomes of people with a psychotic disorder, which is the obvious concern raised by Harrow’s findings, then we really need to rethink the use of these medications in those other populations.Here is a review of the study’s design, and the findings from the two papers.
Read the studies and outcomes here: Interpreting Harrow’s 20-Year Results: Are the Drugs to Blame? | Mad In America.
via Interpreting Harrow’s 20-Year Results: Are the Drugs to Blame? | Mad In America.